Publications by authors named "Declan N C Jones"

37Publications

Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders.

Psychoneuroendocrinology 2018 12 14;98:95-100. Epub 2018 Aug 14.

Neuroscience External Innovation, Johnson & Johnson Innovation Centre, One Chapel Place, London, W1G 0BG, United Kingdom.

View Article and Find Full Text PDF
December 2018

Treatment-resistant depression and peripheral C-reactive protein.

Br J Psychiatry 2019 01 16;214(1):11-19. Epub 2018 May 16.

Immuno-Psychiatry, Immuno-Inflammation Therapeutic Area Unit,GlaxoSmithKline R&D,Stevenage,UK,Cambridgeshire and Peterborough NHS Foundation Trust,Cambridge,UKandDepartment of Psychiatry,University of Cambridge,UK.

View Article and Find Full Text PDF
January 2019

Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychotics.

Psychopharmacology (Berl) 2010 Oct 31;212(2):155-70. Epub 2010 Jul 31.

Biology Department, Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK.

View Article and Find Full Text PDF
October 2010

Models of aspects of schizophrenia: behavioral sensitization induced by subchronic phencyclidine administration.

Curr Protoc Pharmacol 2009 Jun;Chapter 5:Unit 5.54

Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, Essex, UK.

View Article and Find Full Text PDF
June 2009

The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat.

Epilepsy Res 2009 Jul 28;85(1):96-106. Epub 2009 Mar 28.

epartment of Molecular and Cellular Biology, Neuroscience Centre of Excellence for Drug Discovery, Medicines Research Centre, GlaxoSmithKline S.p.A., Via Fleming 4, Verona 37135, Italy.

View Article and Find Full Text PDF
July 2009

Locomotor reactivity to a novel environment and sensitivity to MK-801 in five strains of mice.

Behav Pharmacol 2008 Feb;19(1):71-5

Biology Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Harlow, Essex, UK.

View Article and Find Full Text PDF
February 2008

Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.

Prog Neuropsychopharmacol Biol Psychiatry 2008 Feb 16;32(2):414-22. Epub 2007 Sep 16.

Biology Department, Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
February 2008

Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain.

Brain Res 2007 May 28;1149:50-7. Epub 2007 Feb 28.

Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park North, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
May 2007

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.

Eur J Pharmacol 2006 Sep 21;546(1-3):88-94. Epub 2006 Jul 21.

Psychiatry Centre for Excellence in Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK.

View Article and Find Full Text PDF
September 2006

Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.

Behav Pharmacol 2006 May;17(3):289-92

Schizophrenia and Bipolar Disorders - In Vivo Biology, Psychiatry CEDD, GlaxoSmithKline PLC, New Frontiers Science Park, Harlow, Essex, UK.

View Article and Find Full Text PDF
May 2006

Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data.

Psychopharmacology (Berl) 2006 Jan 7;184(1):107-14. Epub 2005 Dec 7.

Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Third Ave., CM19 5AW Harlow, Essex, UK.

View Article and Find Full Text PDF
January 2006

Predicting drug efficacy for cognitive deficits in schizophrenia.

Schizophr Bull 2005 Oct 21;31(4):830-53. Epub 2005 Sep 21.

Psychiatry Centre of Excellence in Drug Discovery, GlaxoSmithKline plc., Essex, UK.

View Article and Find Full Text PDF
October 2005

Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist.

Psychopharmacology (Berl) 2005 Oct 19;182(2):214-9. Epub 2005 Oct 19.

Psychiatry CEDD, GlaxoSmithKline, Third Avenue, Harlow, CM19 5AW, UK.

View Article and Find Full Text PDF
October 2005

Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.

Psychopharmacology (Berl) 2005 Oct 19;182(2):220-31. Epub 2005 Oct 19.

Schizophrenia and Bipolar Disorders-In vivo Biology, Psychiatry CEDD, GlaxoSmithKline PLC, Harlow, Essex, CM19 5AW, UK.

View Article and Find Full Text PDF
October 2005

Orexin expression and function: glucocorticoid manipulation, stress, and feeding studies.

Endocrinology 2005 Sep 16;146(9):3724-31. Epub 2005 Jun 16.

Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY, United Kingdom.

View Article and Find Full Text PDF
September 2005

5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats.

Psychopharmacology (Berl) 2005 Sep 14;181(2):253-9. Epub 2005 Oct 14.

Schizophrenia and Bipolar Disorders Research, Psychiatry CEDD, Harlow, Essex, UK,

View Article and Find Full Text PDF
September 2005

Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.

Eur J Pharmacol 2004 Nov;505(1-3):253-4

Bradford School of Pharmacy, University of Bradford, Bradford BD7 1DP, UK.

View Article and Find Full Text PDF
November 2004

Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain.

Eur J Pharmacol 2004 Jun;493(1-3):95-8

Psychiatry CEDD, GlaxoSmithKline, Third Avenue, Harlow, Essex CM19 5AW, UK.

View Article and Find Full Text PDF
June 2004

Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism.

Eur J Neurosci 2003 Sep;18(6):1706-10

University Department of Psychiatry, Neurosciences Building, Warneford Hospital, Oxford OX3 7JX, UK.

View Article and Find Full Text PDF
September 2003